Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept Pretreatment Before Vitrectomy in Proliferative Diabetic Retinopathy
ChiCTR-IPR-16007848Phase 4Completed
- Sponsor
- The First People's Hospital of Yunnan Province
- Start
- Mar 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of conbercept in diabetic retinopathy (DR) (2 arms), sponsored by The First People's Hospital of Yunnan Province. Primary endpoints: Best-corrected visual acuity (BCVA), Recurrent vitreous hemorrhage and 1 more. Started Mar 2014; status: completed.
02
Drugs
conbercept
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on ChiCTR-IPR-16007848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007848.